StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultAug 7, 2026, 07:12 AM

Canopy Growth Q1 Net Revenue +13% to $81.2M; EBITDA Loss Narrows 59%

AI Summary

Canopy Growth Corporation reported its first quarter fiscal year 2027 financial results, showing a 13% increase in consolidated net revenue to $81.2 million. The company achieved revenue growth across all business segments, including a 14% rise in cannabis net revenue. Adjusted gross margin improved to 31%, and the adjusted EBITDA loss significantly narrowed by 59% to $3.2 million, reflecting progress in profitability. However, free cash outflow increased to $25.7 million due to changes in working capital.

Key Highlights

  • Consolidated net revenue increased 13% to $81.2M in Q1 FY2027.
  • Cannabis net revenue grew 14% to $65.1M, driven by MTL Cannabis acquisition.
  • Canada medical cannabis net revenue rose 22% to $25.8M.
  • Canada adult-use cannabis net revenue increased 10% to $29.7M.
  • Adjusted gross margin improved to 31% from 25% year-over-year.
  • Adjusted EBITDA loss narrowed by 59% to $3.2M.
  • Net loss was 68% lower at $14.6M compared to Q1 FY2026.
  • Free cash outflow increased to $25.7M from $11.6M.